Revelation Biosciences (REVB) Current Assets (2020 - 2026)
Revelation Biosciences (REVB) posted Current Assets of $11.68 million for Q2 2026, up 118.0% from $5.36 million a year earlier but down 17.7% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Revelation Biosciences' Current Assets came in at $10.81 million, up 64.7% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 75.4% (FY2020 to FY2025).
- In prior years, Revelation Biosciences' Current Assets was $6.57 million in FY2024 (-46.0%), $12.15 million in FY2023 (+124.4%), $5.41 million in FY2022 (+183.1%) and $1.91 million in FY2021 (+193.6%).
- Quarterly Current Assets has run from a low of $39,083 in Q3 2021 to a high of $18.04 million in Q1 2023 over five years.
- On a year-over-year basis, Current Assets has increased in each of the last four quarters, with growth averaging 38.6% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q2 2022, with growth of 984.3%; the weakest was Q3 2021, with a decline of 98.9%.
- According to Business Quant data, Current Assets for the three prior quarters was $14.21 million (Q1 2026), $10.81 million (Q4 2025) and $12.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | 11.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.68 Mn |
| Mar 31, 2026 | 14.21 Mn |
| Dec 31, 2025 | 10.81 Mn |
| Sep 30, 2025 | 12.83 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 6.57 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 12.20 Mn |
| Mar 31, 2024 | 14.62 Mn |
| Dec 31, 2023 | 12.15 Mn |
| Sep 30, 2023 | 14.15 Mn |
| Jun 30, 2023 | 15.96 Mn |
| Mar 31, 2023 | 18.04 Mn |
| Dec 31, 2022 | 5.41 Mn |
| Sep 30, 2022 | 6.51 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 1.91 Mn |
| Sep 30, 2021 | 39,083.00 |
API Access
Revelation Biosciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();